Verge Genomics
2015
United States of America based
$36.120 M
https://www.vergegenomics.com
We are pioneering a better drug discovery process using systems biology to improve the lives of people with neurodegenerative disorders. YC S15.
Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Technologies
AI Companies (Drug Discovery) Pharmaceutical and Drug DiscoveryPosts Mentioning This Company
R&D Platform
Map hundreds of genes that cause a disease, then find drugs that target all at once. Allows researchers to: Find cures for complex diseases—especialy brain diseases—that involve a network of genes.
Pipelines
No pipelines published yet
Products
Services
No services posted yet